Global Health Limited has announced its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. The board also approved the payment of a final dividend of ₹0.50 per equity share for FY 2025-26, subject to shareholder approval at the upcoming AGM. Additionally, the company approved a revised construction plan to increase the bed capacity of its upcoming Guwahati hospital from 400 to 650 beds.
Global Health Announces Q1 FY27 Financials and Dividend Approval
Global Health Limited (GHL) has disclosed its unaudited standalone and consolidated financial results for the first quarter, which concluded on June 30, 2026. These results were approved by the Board of Directors during a meeting held on July 30, 2026. Accompanying the financial results are limited review reports from the statutory auditors, M/s Walker Chandiok & Co LLP.
Dividend Proposal and AGM Details
The company has set August 14, 2026, as the record date for determining shareholder entitlement for the payment of a final dividend for the financial year 2025-26. The proposed dividend is ₹0.50 per equity share. This dividend will be subject to the approval of the shareholders at the 22nd Annual General Meeting (AGM). The AGM is scheduled to be held on Wednesday, September 16, 2026, at 12:00 Noon, via Video Conferencing/Other Audio Video Means (VC/OAVM) facility.
Guwahati Hospital Expansion Approved
In a significant strategic move, the Board of Directors has approved a revised construction plan for the company’s upcoming hospital in Guwahati. This expansion will increase the proposed bed capacity from the initial 400 beds to 650 beds. The estimated project cost for this expansion is ₹970 crores, and it is proposed to be funded through a mix of internal accruals and debt. The project is expected to be added over the next 3-4 years in a phased manner. The company views this expansion as crucial for strengthening healthcare infrastructure in the North East region, serving over 50 million people and addressing the high burden of non-communicable diseases.
Key Executive Appointment
The Board also approved the appointment of Mr. Pradeep Kumar Singh as ‘Chief Digital Officer’ and a Senior Management Personnel (SMP) of the Company, effective July 30, 2026. Mr. Singh brings over 25 years of experience in technology leadership, digital transformation, and enterprise platform development to the role.
Financial Highlights (Standalone)
For the quarter ended June 30, 2026, Global Health Limited reported a total income of ₹11,027.83 million. Total expenses stood at ₹9,196.73 million, resulting in a profit before tax of ₹1,831.10 million. The profit after tax was ₹1,373.07 million. Earnings per share (EPS) for the quarter were ₹5.11 (Basic) and ₹5.10 (Diluted).
Financial Highlights (Consolidated)
On a consolidated basis for the quarter ended June 30, 2026, total income was ₹13,262.15 million. Total expenses amounted to ₹11,129.52 million, leading to a profit before tax of ₹2,132.63 million. The consolidated profit after tax was ₹1,572.52 million. Consolidated EPS stood at ₹5.91 (Basic) and ₹5.90 (Diluted).
Source: BSE
